Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Combivir

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Background:MERIT was a randomized trial comparing maraviroc (MVC) + Combivir versus efavirenz (EFV) + Combivir in drug-naive… Expand
2011
Highly Cited
2009
Highly Cited
2009
Neil Martinson and colleagues report a randomized trial of adding short-course zidovudine+lamivudine to reduce drug resistance… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
2007
2007
Combivir is a fixed dose combination tablet of two antiretroviral drugs; zidovudine and lamivudine, used in the treatment of HIV… Expand
2007
2007
Background: DART is a randomised trial comparing clinical versus clinical plus laboratory monitoring in 3316 HIV-1 infected… Expand
Highly Cited
2006
Highly Cited
2006
To compare the lipid and metabolic effects, efficacy, and safety of twice‐daily regimens of Trizivir® (abacavir 300 mg/lamivudine… Expand
Highly Cited
2004
Highly Cited
2004
Objective: Although most uninfected infants born to women infected with HIV-1 show no clinical evidence of mitochondrial… Expand
Highly Cited
2004
Highly Cited
2004
OBJECTIVE:Preliminary reports suggest that patients with primary biliary cirrhosis (PBC) have evidence of human betaretrovirus… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2003
Highly Cited
2003
Objective: HIV‐1 protease inhibitors (versus no protease inhibitors) and stavudine (versus zidovudine) are independently… Expand
Highly Cited
2002
Highly Cited
2002
BACKGROUND Non-nucleoside reverse transcriptase inhibitor-containing regimens may be a valid alternative to protease inhibitor… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • table 3